Clowes Candadai Sarah V, Sikes Megan C, Thies Jenny M, Freed Amanda S, Bennett James T
Department of Laboratories, Seattle Children's Hospital, Seattle, Washington.
Patient-Centered Laboratory Utilization Guidance Services (PLUGS), Seattle Children's Hospital, Seattle, Washington.
J Genet Couns. 2019 Apr;28(2):283-291. doi: 10.1002/jgc4.1116.
Exome sequencing (ES) has revolutionized molecular diagnosis in children with genetic disease over the past decade. However, exome sequencing in the inpatient setting has traditionally been discouraged, in part due to an increased risk of providers failing to retrieve and act upon results, as many patients are discharged before results return. The development of rapid turn-around-times (TATs) for genomic testing has begun to shift this paradigm. Rapid exome sequencing (rES) is increasingly being used as a diagnostic tool for critically ill infants with likely genetic disease and presents significant challenges to execute. We implemented a program, entitled the Rapid Inpatient Genomic Testing (RIGhT) project, to identify critically ill children for whom a molecular diagnosis is likely to change inpatient management. Two important goals of the RIGhT project were to provide appropriate genetic counseling, and to develop protocols to ensure efficient test coordination- both of which relied heavily on laboratory and clinic-based genetic counselors (GCs). Here, rES was performed on 27 inpatient trios from October 2016 to August 2018; laboratory and clinical GCs encountered significant challenges in the coordination of this testing. The GCs involved retrospectively reviewed these cases and identified three common challenges encountered during pretest counseling and coordination. The aim of this paper is to define these challenges using illustrative case examples that highlight the importance of including GCs to support rES programs.
在过去十年中,外显子组测序(ES)彻底改变了对患有遗传疾病儿童的分子诊断。然而,传统上不鼓励在住院环境中进行外显子组测序,部分原因是由于许多患者在结果返回之前就已出院,导致医疗服务提供者未能获取结果并据此采取行动的风险增加。基因组检测快速周转时间(TAT)的发展已开始改变这一模式。快速外显子组测序(rES)越来越多地被用作患有可能遗传疾病的重症婴儿的诊断工具,并且在执行过程中面临重大挑战。我们实施了一个名为“快速住院基因组检测(RIGhT)项目”的计划,以识别那些分子诊断可能会改变住院治疗管理的重症儿童。RIGhT项目的两个重要目标是提供适当的遗传咨询,并制定方案以确保有效的检测协调——这两者都严重依赖实验室和临床遗传咨询师(GC)。在此,2016年10月至2018年8月期间对27个住院三人组进行了rES检测;参与其中的实验室和临床遗传咨询师在协调此次检测时遇到了重大挑战。相关遗传咨询师回顾性地审查了这些病例,并确定了在检测前咨询和协调过程中遇到的三个常见挑战。本文旨在通过举例说明这些挑战,强调遗传咨询师对支持rES项目的重要性。